Mercer Global Advisors
GRCL

Mercer Global Advisors’s Gracell Biotechnologies Inc. American Depositary Shares GRCL Stock Holding History

Mercer Global Advisors’s Portfolio GRCL Stock Details GRCL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-10,500
Closed -$24K – 2076
2022
Q4 		$24K Buy
+10,500
New +$24K ﹤0.01% 1901